Loading chat...
GA HB963
Bill
Status
Passed
5/13/2022
Primary Sponsor
Butch Parrish
Click for details
AI Summary
- Adds brorphine, tianeptine, para-methoxymethamphetamine (PMMA), 4,4'-dimethylaminorex, and methiopropamine to the Schedule I controlled substances list under Georgia law
- Adds fluclotizolam and serdexmethylphenidate to the Schedule IV controlled substances list
- Expands the structural definition of Schedule I synthetic cannabinoids to cover additional chemical substitutions, including alkyl, alkoxy, or cyclic substitutions at the 3-position and amine groups
- Adds approximately 60 new pharmaceutical substances to the state's dangerous drug list, including COVID-19 mRNA vaccine, various cancer therapies, and other recently approved medications
- Creates exceptions for alcaftadine (at 0.25% or less in ophthalmic solution) and azelastine hydrochloride (at 0.15% or less in nasal spray) from dangerous drug classification, and becomes effective upon the Governor's approval
Legislative Description
Controlled substances; Schedule I and IV; change certain provisions
Last Action
Effective Date 2022-05-13
5/13/2022
Committee Referrals
Public Safety2/15/2022
Health and Human Services1/25/2022
Full Bill Text
No bill text available